Search by Drug Name or NDC

NDC 24338-0260-08 Nymalize 60 mg/10mL Details

Nymalize 60 mg/10mL

Nymalize is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Azurity Pharmaceuticals, Inc.. The primary component is NIMODIPINE.

MedlinePlus Drug Summary

Nimodipine is used to decrease brain damage that may be caused by a subarachnoid hemorrhage (bleeding in the space surrounding the brain that occurs when a weakened blood vessel in the brain bursts). Nimodipine is in a class of medications called calcium channel blockers. It works by relaxing blood vessels in the brain to allow more blood to flow to damaged areas.

Related Packages: 24338-0260-08
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Nimodipine

Product Information

NDC	24338-0260
Product ID	24338-260_8c3aba10-0b86-4b03-8952-adc2a2b950b4
Associated GPIs	34000022002054
GCN Sequence Number	082451
GCN Sequence Number Description	nimodipine SOLUTION 60 MG/10ML ORAL
HIC3	A9A
HIC3 Description	CALCIUM CHANNEL BLOCKING AGENTS
GCN	48405
HICL Sequence Number	000184
HICL Sequence Number Description	NIMODIPINE
Brand/Generic	Brand
Proprietary Name	Nymalize
Proprietary Name Suffix	n/a
Non-Proprietary Name	nimodipine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	SOLUTION
Route	ORAL
Active Ingredient Strength	60
Active Ingredient Units	mg/10mL
Substance Name	NIMODIPINE
Labeler Name	Azurity Pharmaceuticals, Inc.
Pharmaceutical Class	Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA203340
Listing Certified Through	2024-12-31

Package

NDC 24338-0260-08 (24338026008)

Pricing Information	N/A
NDC Package Code	24338-260-08
Billing NDC	24338026008
Package	237 mL in 1 BOTTLE (24338-260-08)
Marketing Start Date	2021-07-13
NDC Exclude Flag	N